2020
DOI: 10.1186/s12883-020-01796-z
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features of Guillain–Barré syndrome patients with elevated serum creatine kinase levels

Abstract: Background: It is not well defined whether Guillain-Barré syndrome (GBS) patients with elevated serum creatine kinase (CK) levels have characteristic clinical features and are related to the subgroups of GBS. Methods: We retrospectively studied 51 consecutive patients with GBS, who visited our hospital, and compared clinical, laboratory and electrophysiological findings between patients with and without elevated CK levels. Results: Of 51 patients, 14 patients (27%) showed an elevation of serum CK levels. When … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 38 publications
2
14
0
Order By: Relevance
“…In a retrospective study of 72 patients, transient hyperCKemia in GBS was significantly associated with male sex and non-demyelinating electrodiagnostic subtype, but not with other clinical features, in- cluding disability or the nature of pain [9]. In another study of 51 patients, GBS patients with elevated CK levels represented a group of AMAN, and elevated CK tended to occur during the acute phase of AMAN following upper respiratory tract infection [10].…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…In a retrospective study of 72 patients, transient hyperCKemia in GBS was significantly associated with male sex and non-demyelinating electrodiagnostic subtype, but not with other clinical features, in- cluding disability or the nature of pain [9]. In another study of 51 patients, GBS patients with elevated CK levels represented a group of AMAN, and elevated CK tended to occur during the acute phase of AMAN following upper respiratory tract infection [10].…”
Section: Discussionmentioning
confidence: 94%
“…Table 2 highlights the published cases in the literature on GBS with hyperCKemia with/without other manifestations [4][5][6][7][8][9][10]. Satoh et al [7] reported a case of cramping pain with prolonged elevation of serum CK levels in a patient with GBS.…”
Section: Discussionmentioning
confidence: 99%
“…The patient also noted to have high CPK levels which was thought to be secondary to metabolic cause such as hypothyroidism. However, there is evidence in the current medical literature that CPK alterations may be seen in up to 27% of patients with GBS in the first 4 weeks after symptoms’ onset [ 18 ]. Moreover, patients presenting with CPK alterations usually have a form of AMSAN with reversible conduction failure (RCF).…”
Section: Discussionmentioning
confidence: 99%
“…Given the absence of brainstem involvement from PRES or other vascular insults, the unilateral facial paralysis in our patient may have been related to an immune-mediated facial neuropathy as a separate sequela of post-COVID-19 illness with GBS. Several case reports and series have described a relationship between COVID-19 and facial paralysis with and without association with GBS [ 3 , 17 , 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Some patients initially experience muscle pain or nerve root pain ( 2 ). During the course of GBS, 16–27% of patients show an elevation of serum creatine kinase (CK) levels ( 3 , 4 ) but only rarely is GBS complicated with rhabdomyolysis (RML) ( 5 9 ). The research history of GBS in Beijing Children's Hospital (BCH), which is affiliated with Capital Medical University, can be traced back to the 1990s.…”
Section: Introductionmentioning
confidence: 99%